Pharma companies are learning to share. That is, when it comes to clinical research data, according to findings from the Good Pharma Scorecard biennial ranking. Now in its third edition, the research found Big Pharma data sharing around clinical research on the upswing, with 95% of patient trials now providing public results within six months […]

FSD Pharma Inc. announced this week it closed a deal to acquire Prismic Pharmaceuticals, a U.S.-based specialty pharmaceutical company dedicated to addressing the opioid crisis. Through the utilization of its micro-PEA platform, the company seeks to develop novel, non-addictive prescription drugs. Such formulations impact the endocannabinoid system. This means that lower doses of drugs can be used […]

CEO and Chairman of Emmaus Life Sciences, Dr. Yutaka Niihara, discusses expanding the application of pharmaceutical-grade L-glutamine (PGLG) as a therapeutic for sickle cell disease to investigating its potential in treating type II diabetes. Emmaus is set to conduct a clinical study in collaboration with the Straub Medical Center to explore the role of PGLG in […]